In the UK, meclonazepam has been classified as a
Class C drug by the May 2017 amendment to
The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs.[9]
^O'Boyle C, Lambe R, Darragh A (1985). "Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam". European Journal of Clinical Pharmacology. 29 (1): 105–108.
doi:
10.1007/bf00547377.
PMID4054198.
S2CID1150292.
^Meyer MR, Bergstrand MP, Helander A, Beck O (May 2016). "Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes". Analytical and Bioanalytical Chemistry. 408 (13): 3571–3591.
doi:
10.1007/s00216-016-9439-6.
PMID27071765.
S2CID25831532.
^Pettersson Bergstrand M, Helander A, Hansson T, Beck O (April 2017). "Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays". Drug Testing and Analysis. 9 (4): 640–645.
doi:
10.1002/dta.2003.
PMID27366870.
Abdul-Ghani RA, Loutfy N, Hassan A (October 2009). "Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use". Parasitology Research. 105 (4): 899–906.
doi:
10.1007/s00436-009-1546-2.
PMID19588166.
S2CID24122988.